7.17

0.99% 0.07

After Hours: 7.32 0.15 +2.09%

Terns Pharmaceuticals Inc (TERN)

Overview News Price History Option Chain Financials Discussions Forecast

Terns Pharmaceuticals Inc stock is traded at $7.17, with a volume of 805.10K. It is up +0.99% in the last 24 hours and down -13.30% over the past month. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Previous Close:

$7.10

Open:

$7.03

24h Volume:

805.10K

Relative Volume:

0.43

Market Cap:

$605.41M

Revenue:

Net Income/Loss:

$-95.90M

P/E Ratio:

-5.5581

EPS:

-1.29

Net Cash Flow:

$-79.09M

1W Performance:

+4.22%

1M Performance:

-13.30%

6M Performance:

+31.80%

1Y Performance:

+47.53%

1-Day Range:

$6.94

$7.215

1-Week Range:

$6.49

$7.345

52-Week Range:

$3.26

$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Name

Terns Pharmaceuticals Inc

Sector

Healthcare (1182)

Industry

Biotechnology (671)

Phone

650-525-5535 EXT.101

Address

1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

TERN's Discussions on Twitter

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-08-23	Initiated	BMO Capital Markets	Outperform
Feb-14-23	Initiated	JMP Securities	Mkt Outperform
Feb-07-23	Initiated	UBS	Buy
Sep-12-22	Initiated	H.C. Wainwright	Neutral
Sep-14-21	Resumed	Goldman	Buy
Mar-02-21	Initiated	Cowen	Outperform
Mar-02-21	Initiated	Goldman	Buy
Mar-02-21	Initiated	JP Morgan	Overweight

View All

Terns Pharmaceuticals Inc Stock (TERN) Latest News

Nov 04, 2024

Terns Surges 29.6% in Three Months: Will the Momentum Continue? - MSN

Nov 04, 2024

Nov 03, 2024

Critical Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Terns Pharmaceuticals (NASDAQ:TERN) - Defense World

Nov 03, 2024

Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $15.90 - Defense World

Nov 03, 2024

Oct 31, 2024

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Oct 31, 2024

Oppenheimer initiates Terns Pharmaceuticals stock at Outperform, sees 150% upside - Investing.com Australia

Oct 31, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $15.90 Average Target Price from Analysts - MarketBeat

Oct 31, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Coverage Initiated by Analysts at Oppenheimer - MarketBeat

Oct 31, 2024

Oct 26, 2024

Objective long/short (TERN) Report - Stock Traders Daily

Oct 26, 2024

Oct 25, 2024

Bleakley Financial Group LLC Purchases 2,751 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Oct 25, 2024

Oct 23, 2024

SG Americas Securities LLC Buys Shares of 23,810 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Oct 23, 2024

Financial Comparison: Oculis (NASDAQ:OCS) and Terns Pharmaceuticals (NASDAQ:TERN) - Defense World

Oct 23, 2024

Oct 21, 2024

Will The LIFT Data Boost Terns Stock? - RTTNews

Oct 21, 2024

Terns Pharmaceuticals: Another Potential GLP-1 Entrant (NASDAQ:TERN) - Seeking Alpha

Oct 21, 2024

Oct 16, 2024

Top investors say Terns Pharmaceuticals Inc (TERN) ticks everything they need - SETE News

Oct 16, 2024

(TERN) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 16, 2024

Oct 15, 2024

A stock that deserves closer examination: Terns Pharmaceuticals Inc (TERN) - US Post News

Oct 15, 2024

Oct 14, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Short Interest Update - MarketBeat

Oct 14, 2024

Mizuho gives a Buy recommendation for Terns Pharmaceuticals Inc (TERN) - Knox Daily

Oct 14, 2024

Why Terns Pharmaceuticals Inc Stock Might Make Sense If Bought Today - Stocks Register

Oct 14, 2024

Oct 13, 2024

Marshall Wace LLP Decreases Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Oct 13, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Sold by Marshall Wace LLP - MarketBeat

Oct 13, 2024

Oct 11, 2024

Institutional investors in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) lost 9.7% last week but have reaped the benefits of longer-term growth - Simply Wall St

Oct 11, 2024

Oct 10, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 6.2%Here's Why - MarketBeat

Oct 10, 2024